Albitar Company
FDA import alert and refusal historySharjah, United Arab EmiratesFEI 1000185436
As of October 26, 2026, Albitar Company (Sharjah, United Arab Emirates) is on the red list of FDA Import Alert 99-19 (Food products: Salmonella) for tahinah (ground sesame seeds), published by FDA on September 16, 2009, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-19 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Albitar Company
1 record, newest first. Each line links to the FDA page it came from.
2009
- Import alert listingListed on Import Alert 99-19red listTahinah (ground sesame seeds)Source
Questions about Albitar Company
- Is Albitar Company on an FDA import alert?
- Yes. As of October 26, 2026, Albitar Company is on the red list of FDA Import Alert 99-19, “Food products: Salmonella”, for tahinah (ground sesame seeds); FDA published the listing on September 16, 2009.
- Has FDA refused shipments from Albitar Company?
- No FDA import refusals for Albitar Company appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Albitar Company's FEI number?
- Albitar Company's FDA Establishment Identifier (FEI) is 1000185436.
- Can shipments from Albitar Company still enter the U.S.?
- Shipments of tahinah (ground sesame seeds) from Albitar Company can be detained without physical examination under Import Alert 99-19; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Albitar Company?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.